Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 202

1.

Assessment of potential drug-drug interactions with a prescription claims database.

Malone DC, Hutchins DS, Haupert H, Hansten P, Duncan B, Van Bergen RC, Solomon SL, Lipton RB.

Am J Health Syst Pharm. 2005 Oct 1;62(19):1983-91. Erratum in: Am J Health Syst Pharm. 2006 Feb 1;63(3):201.

PMID:
16174833
2.

Prevalence and predictors of potential drug-drug interactions in Regione Emilia-Romagna, Italy.

Gagne JJ, Maio V, Rabinowitz C.

J Clin Pharm Ther. 2008 Apr;33(2):141-51. doi: 10.1111/j.1365-2710.2007.00891.x.

PMID:
18315779
3.

Potential drug-drug interactions within Veterans Affairs medical centers.

Mahmood M, Malone DC, Skrepnek GH, Abarca J, Armstrong EP, Murphy JE, Grizzle AJ, Ko Y, Woosley RL.

Am J Health Syst Pharm. 2007 Jul 15;64(14):1500-5.

PMID:
17617500
4.

Pharmacist workload and pharmacy characteristics associated with the dispensing of potentially clinically important drug-drug interactions.

Malone DC, Abarca J, Skrepnek GH, Murphy JE, Armstrong EP, Grizzle AJ, Rehfeld RA, Woosley RL.

Med Care. 2007 May;45(5):456-62.

PMID:
17446832
5.

Clinically important potential drug-drug interactions in outpatient settings.

Aparasu R, Baer R, Aparasu A.

Res Social Adm Pharm. 2007 Dec;3(4):426-37.

PMID:
18082877
6.

Potential drug-drug interactions in prescriptions dispensed in community pharmacies in Greece.

Chatsisvili A, Sapounidis I, Pavlidou G, Zoumpouridou E, Karakousis VA, Spanakis M, Teperikidis L, Niopas I.

Pharm World Sci. 2010 Apr;32(2):187-93. doi: 10.1007/s11096-010-9365-1. Epub 2010 Jan 14.

PMID:
20077137
7.

Prevalence of possible drug-drug interactions between antiretroviral agents in different age groups in a section of the private health care sector setting in South Africa.

Katende-Kyenda NL, Lubbe MS, Serfontein JH, Truter I.

J Clin Pharm Ther. 2008 Aug;33(4):393-400. doi: 10.1111/j.1365-2710.2008.00930.x.

PMID:
18613857
8.

Measuring patient safety in ambulatory care: potential for identifying medical group drug-drug interaction rates using claims data.

Solberg LI, Hurley JS, Roberts MH, Nelson WW, Frost FJ, Crain AL, Gunter MJ, Young LR.

Am J Manag Care. 2004 Nov;10(11 Pt 1):753-9.

10.

Drug-drug interactions associated with length of stay and cost of hospitalization.

Moura CS, Acurcio FA, Belo NO.

J Pharm Pharm Sci. 2009;12(3):266-72.

11.

Prescribers' knowledge of and sources of information for potential drug-drug interactions: a postal survey of US prescribers.

Ko Y, Malone DC, Skrepnek GH, Armstrong EP, Murphy JE, Abarca J, Rehfeld RA, Reel SJ, Woosley RL.

Drug Saf. 2008;31(6):525-36.

PMID:
18484786
12.

Potential for alcohol and prescription drug interactions in older people.

Pringle KE, Ahern FM, Heller DA, Gold CH, Brown TV.

J Am Geriatr Soc. 2005 Nov;53(11):1930-6.

PMID:
16274374
13.
14.

Potential drug interactions during a three-decade study period: a cross-sectional study of a prescription register.

Astrand E, Astrand B, Antonov K, Petersson G.

Eur J Clin Pharmacol. 2007 Sep;63(9):851-9. Epub 2007 Jun 28. Erratum in: Eur J Clin Pharmacol. 2007 Nov;63(11):1095.

PMID:
17598096
15.

Identification of severe potential drug-drug interactions using an Italian general-practitioner database.

Magro L, Conforti A, Del Zotti F, Leone R, Iorio ML, Meneghelli I, Massignani D, Visonà E, Moretti U.

Eur J Clin Pharmacol. 2008 Mar;64(3):303-9. Epub 2007 Nov 9.

PMID:
17992523
16.

Increasing exposure to drug-drug interactions between 1992 and 2005 in people aged > or = 55 years.

Becker ML, Visser LE, van Gelder T, Hofman A, Stricker BH.

Drugs Aging. 2008;25(2):145-52.

PMID:
18257601
17.

Prevalence, incidence and persistence of antipsychotic drug prescribing in the Italian general population: retrospective database analysis, 1999-2002.

Mirandola M, Andretta M, Corbari L, Sorio A, Nosè M, Barbui C.

Pharmacoepidemiol Drug Saf. 2006 Jun;15(6):412-20.

PMID:
16287199
18.

Diffusion into use of exenatide for glucose control in diabetes mellitus: a retrospective cohort study of a new therapy.

Segal JB, Dy SM, Millman EA, Herbert R, Bass EB, Wu A.

Clin Ther. 2007 Aug;29(8):1784-94.

PMID:
17919559
19.

Utilization of, and adherence to, drug therapy among medicaid beneficiaries with congestive heart failure.

Bagchi AD, Esposito D, Kim M, Verdier J, Bencio D.

Clin Ther. 2007 Aug;29(8):1771-83.

PMID:
17919558
20.

Relationship between pharmaceutical services characteristics and exposure rates to drug-drug interactions in Veterans Affairs medical centers.

Mahmood MH, Armstrong EP, Malone DC, Skrepnek GH.

Am J Health Syst Pharm. 2008 Sep 15;65(18):1744-9. doi: 10.2146/ajhp070679.

PMID:
18769002
Items per page

Supplemental Content

Write to the Help Desk